title: Imaging of Fluid in Cancer Patients Treated With Systemic Therapy: Chemotherapy, Molecular Targeted Therapy, and Hematopoietic Stem Cell Transplantation.
abstract: OBJECTIVE
  The purpose of this article is to provide a comprehensive review of the imaging features of various systemic treatment-related causes of fluid accumulation in cancer patients.
  
  
  CONCLUSIONS
  Systemic treatment-related fluid accumulation can occur with chemotherapy, molecular targeted therapy, or hematopoietic stem cell transplantation. Imaging findings such as new ascites, pleural and pericardial effusions, and subcutaneous edema should be interpreted with caution on restaging studies.
authors.affiliation: 1 All authors: Department of Imaging, Dana Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA 02215.|2 All authors: Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
authors.forename: Abhishek R
authors.initials: AR
authors.lastname: Keraliya
authors.affiliation: 1 All authors: Department of Imaging, Dana Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA 02215.|2 All authors: Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
authors.forename: Michael H
authors.initials: MH
authors.lastname: Rosenthal
authors.affiliation: 1 All authors: Department of Imaging, Dana Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA 02215.|2 All authors: Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
authors.forename: Katherine M
authors.initials: KM
authors.lastname: Krajewski
authors.affiliation: 1 All authors: Department of Imaging, Dana Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA 02215.|2 All authors: Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
authors.forename: Jyothi P
authors.initials: JP
authors.lastname: Jagannathan
authors.affiliation: 1 All authors: Department of Imaging, Dana Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA 02215.|2 All authors: Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
authors.forename: Atul B
authors.initials: AB
authors.lastname: Shinagare
authors.affiliation: 1 All authors: Department of Imaging, Dana Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA 02215.|2 All authors: Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
authors.forename: Sree Harsha
authors.initials: SH
authors.lastname: Tirumani
authors.affiliation: 1 All authors: Department of Imaging, Dana Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA 02215.|2 All authors: Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
authors.forename: Nikhil H
authors.initials: NH
authors.lastname: Ramaiya
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D001201:Ascites / Q000175:diagnosis / Q000209:etiology; D003952:Diagnostic Imaging; D004487:Edema / Q000175:diagnosis* / Q000209:etiology; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D058990:Molecular Targeted Therapy / Q000009:adverse effects*; D009369:Neoplasms / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D010490:Pericardial Effusion / Q000175:diagnosis / Q000209:etiology; D010996:Pleural Effusion / Q000175:diagnosis / Q000209:etiology
chemical_list: D000970:Antineoplastic Agents
keywords: fluid; hematopoietic stem cell transplantation; molecular targeted therapy